S. D. Gillies

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

Medicine, Immunology, Oncology +14

Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.

Alice L. Yu, M. M. Uttenreuther-Fischer, Chiun‐Sheng Huang et al. · Journal of Clinical Oncology · 1998 · 253 citations

Pharmacy, Oncology, Pharmacokinetics +17

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma

R. Handgretinger, Kelly E. Anderson, Peter Lang et al. · European Journal of Cancer · 1995 · 213 citations

Medicine, Immunology, Oncology +6

Targeted Interleukin-2 Therapy for Spontaneous Neuroblastoma Metastases to Bone Marrow

Holger N. Lode, Rong Xiang, Carrie S. Dolman et al. · JNCI Journal of the National Cancer Institute · 1997 · 169 citations · Full text

Life Sciences, Immunology, Oncology +16

An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response.

Jürgen C. Becker, Nissi Varki, S. D. Gillies et al. · Proceedings of the National Academy of Sciences · 1996 · 103 citations

Medicine, Immunology, Oncology +17